Merel M. C. Lambregts

Time to positivity of blood cultures supports early re-evaluation of empiric broad-spectrum antimicrobial therapy

Merel M. C. Lambregts, A.T. Bernards, Martha T. van der Beek et al. · PLoS ONE · 2019 · 86 citations · Full text

HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study

Colette Smit, Anders Boyd, Bart Rijnders et al. · The Lancet HIV · 2020 · 72 citations · Full text

Retrospective Cohort Study, Treatment And Prevention, Human Retrovirus +9

Global Differences in the Management of <i>Staphylococcus aureus</i> Bacteremia: No International Standard of Care

Annette C. Westgeest, David T.P. Buis, Kim Sigaloff et al. · Clinical Infectious Diseases · 2023 · 39 citations · Full text

Current Pyuria Cutoffs Promote Inappropriate Urinary Tract Infection Diagnosis in Older Women

Manu P. Bilsen, Margaretha J. Aantjes, Esther van Andel et al. · Clinical Infectious Diseases · 2023 · 37 citations · Full text

Distribution and clinical determinants of time‐to‐positivity of blood cultures in patients with neutropenia

Merel M. C. Lambregts, Eva B. Warreman, A.T. Bernards et al. · European Journal Of Haematology · 2017 · 20 citations